Find a Doctor
To find your closest EVO ICL doctor, start by searching your location.
3+ million lenses distributed worldwide
Sort by:
Brian Foster, MD
The Eye Associates - Sarasota
Set Up A Consultation
Contact this office directly and mention your interest in EVO ICL
(866) 377-9593
Joaquin O. De Rojas, MD
Center For Sight- Sarasota
Set Up A Consultation
Contact this office directly and mention your interest in EVO ICL
(941) 277-9040
Priya M. Mathews, MD MPH
Center For Sight- Sarasota
Set Up A Consultation
Contact this office directly and mention your interest in EVO ICL
(941) 277-9040
Office Information
Center For Sight- Sarasota
Office Hours
- Today
- 8:00AM-5:00PM
About this Doctor
Dr. Priya Mathews is a board-certified, fellowship-trained refractive surgeon at Center For Sight. She earned her Bachelor of Science degree in Biological Sciences and Bachelor of Arts degree in Psychology from the University of Maryland, graduating summa cum laude and valedictorian of her class. She received her Medical Degree from Johns Hopkins University, and also earned her Master’s in Public Health, with a concentration in epidemiology and biostatistics, at the Johns Hopkins Bloomberg School of Public Health. Dr. Mathews completed her ophthalmology residency at Harkness Eye Institute at Columbia University Medical Center in New York City, followed by a fellowship in Refractive Surgery at Johns Hopkins Wilmer Eye Institute.
Dr. Mathews specializes in various forms of refractive surgery. Dr. Mathews is dedicated to offering to her patients the most advanced surgeries and procedures available, including the EVO ICL procedure.
Dr. Mathews has extensive scientific research experience, publishing over 30 peer-reviewed publications in top medical journals. She is a member of the American Academy of Ophthalmology (AAO), the American Society for Cataract and Refractive Surgery (ASCRS), Women in Ophthalmology (WIO), and the International Society of Refractive Surgery. Additionally, Dr. Mathews has a particular interest in combatting the global burden of corneal blindness. She has volunteered for numerous medical and surgical mission trips around the world, including Haiti, Guatemala, India, The Philippines, and Bolivia. She has received multiple grants to support related initiatives, including the ASCRS International Service Grant and the prestigious AAO Hoskins Center IRIS Registry Research Fund Award. Dr. Mathews is the cofounder and Executive Vice President of Keratoplasty Alliance International, a nonprofit organization which aims to discover and develop novel methods of increasing the supply of donor corneal tissue worldwide.
Dr. Mathews lives in Sarasota with her husband, Joaquin, and their two young children, Isabella and Leonardo. She is a certified Vinyasa and Hatha yoga instructor and practices daily to strengthen and rejuvenate her body, mind, and spirit.
Certification and Association
- American Board of Ophthalmology
Education
- Undergraduate Degree- University of Maryland
- Medical Degree- Johns Hopkins University
- Master's Degree- Johns Hopkins Bloomberg School of Public Health
- Residency- Harkness Eye Institute at Columbia University Medical Center
- Fellowship- Johns Hopkins Wilmer Eye Institute
Call today to set up a consultation for EVO ICL
(941) 277-9040Select Your Region
Latin America
References
1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
2. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.
3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53.
4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.
5. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263.
6. Naves J.S, Carracedo G, Cacho-Babillo I, Diadenosine nucleotid measurements as dry-eye score in patients after LASIK and ICL surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
7. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
8. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
9. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
This provider locator tool is being provided by STAAR Surgical® Company (“STAAR”) solely to assist users in locating a provider who has experience with the EVO ICL family of lenses, as explained further here. Specifically, the sole criteria for inclusion in the locator is whether a provider is certified by STAAR to implant EVO ICL lenses. Users may search the locator by zip code, state, or current location. Two types of sorting functionality is available within the locator. Users are able to sort the results via distance, or by the frequency with which a healthcare provider has recently used EVO ICL lenses (e.g., within the past 12 months). Irrespective of the sorting method selected, all providers are shown in the results within the queried geographic location. The listed order of providers under any sorting method, including the initial presentation of providers in a geographic location, is based on a variety of factors, including whether the provider maintains consumer-facing information about EVO ICL lenses on its website, the breadth and quality of such information, whether it has demonstrated a commitment to training staff and offering the EVO ICL as a refractive procedure option to qualified patients, and how frequently the provider has performed procedures using the EVO ICL over the past year.
Notwithstanding the above, this provider locator tool should not be construed in any way as an endorsement or recommendation by STAAR as to the qualifications of any provider listed in this tool or the quality of medical care they can provide. STAAR makes no guarantees that using a provider from this list will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential provider. STAAR recommends that you meet and discuss the benefits and risks of the EVO ICL lens, and the procedure to implant the EVO ICL lens with the potential provider.
STAAR hereby disclaims any and all liability arising from your use of and/or reliance on the information contained in this provider locator tool.
Important Safety Information
The EVO Visian ICL Lens is intended for the correction of moderate to high nearsightedness. EVO Visian ICL and EVO Visian TICL surgery is intended to safely and effectively correct nearsightedness between -3.0 D to -15.0 D, the reduction in nearsightedness up to -20.0 D and treatment of astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before.
Implantation of the EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. Please discuss the risks with your eye care professional. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts.
You should NOT have EVO Visian ICL surgery if:
- Your doctor determines that the shape of your eye is not an appropriate fit for the EVO Visian ICL
- You are pregnant or nursing
- You have moderate to severe damage to the optic nerve caused by increased pressure (glaucoma)
- You do not meet the minimum endothelial cell density for your age at the time of implantation as determined by your eye doctor
- Your vision is not stable as determined by your eye doctor
Before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. For additional information with potential benefits, risks and complications please visit DiscoverICL.com.
Feeling unsure?
We get it. Decisions like this take time to consider and research. We can help guide your decision with information that's the most relevant to you.
Do you currently wear glasses or contacts?